In vivo evalution of hypoglycemic activity of Aloe spp. and identification of its mode of Action on GLUT-4 gene expression in vitro

Applied Biochemistry and Biotechnology

Volumn 164, Issue 8, 2011, Pages 1246-1256

  Kumar, Rajiv ^a   Sharma, Bhavna ^b   Tomar, Neha R ^a   Roy, Partha ^b   Gupta, Atul K ^a   Kumar, Anil ^a  

^a G B PANT UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Aloe extract; Diabetes mellitus; Glucose tolerance test; GLUT 4 gene; Hexokinase assay; In vitro; In vivo; Lipid profile; NIH 3T3 cells

Indexed keywords

ALOE EXTRACT; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; GLUT-4 GENE; HEXOKINASES; IN VITRO; IN VIVO; LIPID PROFILE; NIH/3T3 CELLS;

ANTHROPOMETRY; CARBOHYDRATES; CELL CULTURE; GLUCOSE; MAMMALS; MEDICAL PROBLEMS; SOLVENT EXTRACTION;

GENE EXPRESSION;

ALOE VERA EXTRACT; CHOLESTEROL; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; GLYCOGEN; HEXOKINASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METFORMIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ANTIDIABETIC AGENT; LIPID; MESSENGER RNA; PLANT EXTRACT; SLC2A4 PROTEIN, MOUSE;

ALOE VERA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL STRAIN 3T3; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; MOUSE; NONHUMAN; SPECTROSCOPY; STREPTOZOCIN DIABETES; ALOE; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE TOLERANCE TEST; LIVER; MEDICINAL PLANT; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY TESTING; UPREGULATION;

ALOE; MUS;

ACUTE TOXICITY TESTS; ALOE; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; GLUCOSE-6-PHOSPHATASE; GLYCOGEN; HEXOKINASE; HYPOGLYCEMIC AGENTS; LIPIDS; LIVER; MICE; NIH 3T3 CELLS; PLANT EXTRACTS; PLANTS, MEDICINAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 80052454400     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-011-9210-6     Document Type: Article

References (30)

1. Arky, R. A. (1982). Clinical correlates of metabolic derangements of diabetes mellitus. In G. P. Kozak (Ed.), Complications of diabetes mellitus (pp. 16-20). Philadelphia: W.B. Saunders.
2. Marcovecchio, M., Mohn, A., & Chiarelli, F. (2005). Type 2 diabetes mellitus in children and adolescents. Journal of Endocrinology Investigation, 28, 853-863. (Pubitemid 43162846)
3. Wild, S., Roglie, G., Green, A., et al. (2004). Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047-1059.
4. Bailey, L. J., & Day, C. (1989). Traditional plant medicine as treatment for diabetes. Diabetes Care, 12, 553-564.
5. Bunyapraphatsara, N., Chasrakaew, W., Pornchirasilp, S., et al. (1995). Antidiabetic effect of fresh and preserved Aloe gel. Thai Journal of Phytopharmacy, 2, 1-7.
6. Yongchaiyudha, S., Rungpitarangsi, V., Bunyapraphatsara, N., et al. (1996). Antidiabetic activity of Aloe vera juice l. Clinical trial in new cases of diabetes mellitus. Phytomedicine, 3, 241-243. (Pubitemid 126504564)
7. Yagi, A., Hegazy, S., Kabbash, A., et al. (2009). Possible hypoglycemic effect of Aloe vera L. high molecular weight fractions on type 2 diabetic patients. Saudi Pharmaceutical Journal, 17(3), 210-217.
8. Ajbanoor, M. A. (1990). Effects of Aloes on blood glucose levels in normal and Alloxan-diabetic mice. Journal of Ethnopharmacology, 28, 215-220.
9. Beppu, H., Nagamura, Y., & Fujita, K. (1993). Hypoglycaemic and anti-diabetic effects in mice of Aloe arborescens Miller var. natalensis Berger. Phytotherapy Research, 7, S37-S42. (Pubitemid 23106496)
10. Beppu, H., Shimpo, K., Chihara, T., et al. (2006). Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice, investigation on hypoglycemic action and systemic absorption dynamics of Aloe components. Journal of Ethnopharmacology, 103, 468-477. (Pubitemid 43143385)
11. Rajasekaran, S., Sivagnanam, K., Ravi, K., et al. (2004). Hypoglycemic effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats. Journal of Medicinal Food, 7, 61-66. (Pubitemid 38445924)
12. Rajasekaran, S., Sivagnanam, K., & Subramanian, S. (2005). Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin. The Journal of Pharmacy and Pharmacology, 57, 241-246. (Pubitemid 40129093)
13. Rajasekaran, S., Ravi, K., Sivagnanam, K., et al. (2006). Beneficial effects of Aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clinical and Experimental Pharmacology & Physiology, 33, 232-237.
14. Kim, K., Kim, H., Kwon, J., et al. (2009). Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine, 16, 856-863.
15. Gbolade, A. A. (2009). Inventry of antidiabetic plants in selected districts of lagos state, Nigeria. Journal of Ethnopharmacology, 121, 135-139.
16. Ghannam, N., & Geissman, E. S. (1986). The anti-diabetic activity of Aloes, preliminary clinical and experimental observations. Hormone Research, 24, 288-294. (Pubitemid 16004133)
17. Schaftingen, E. V., & Gerin, I. (2002). The glucose-6-phosphatase system. Journal of Biochemistry, 362, 513-532. (Pubitemid 34242301)
18. Brandstrup, N., Kirk, J. E., & Bruni, C. (1957). Determination of hexokinase in tissues. Journal of Gerontology, 12, 166-171.
19. Sadasivam, S., & Manickam, A. (1996). Carbohydrates. In S. Sadasivam & A. Manickam (Eds.), Methods in biochemistry (pp. 11-12). New Delhi: New Age International Private Limited.
20. Obata, M., Ito, S., & Beppu, H. (1993). Mechanism of antiinflammatory and antithermal burn action of Cpase from Aloe arborescence Miller var. natalensis berger in rats and mice. Phytotherapy Reasearch, 7 (7), S30-S33. (Pubitemid 23106494)
21. Hamman, J. H. (2008). Composition and applications of Aloe vera gel. Molecules, 13, 1599-1616.
22. Vella, S., Buetlow, L., Royle, P., et al. (2010). The use of metformin in type 1 diabetes: a systemic review of efficacy. Diabetologia, 53(5), 809-820.
23. Perkins, J. M., & Davis, S. N. (2007). The rationale for prandial glycemic control in diabetes mellitus. Insulin, 2(2), 52-60. (Pubitemid 47324331)
24. Valdivielso, P., Puerta, S., Rioja, J., et al. (2010). Postprandial apolipopreotein B48 is associated with asymptomatic peripheral arterial diseases, a study in patients with type 2 diabetes and controls. Clinica Chimica Acta, 411, 433-437.
25. Liu, K., Paterson, A. J., Konard, R. J., et al. (2002). Streptozotocin, an O-Glc NAcase inhibitor, blunts insulin and growth hormone secretion. Molecular and Cellular Endocrinology, 194, 135-146. (Pubitemid 35291928)
26. Mueckler, M. (1994). Facilitative glucose transporters. European Journal of Biochemistry, 219, 713-725. (Pubitemid 24050938)
27. Hundal, H. S., Ramlal, T., Reyes, R., et al. (1992). Cellular mechanism of Metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscles cells. Endocrinology, 131, 1165-1173.
28. Galuska, D., Nolte, L. A., Zierath, J. R., et al. (1994). Effects of Metformin on insulin-stimulated glucose transport in isolated skeletal muscles obtained from patients with NIDDM. Diabetologia, 37, 826-832. (Pubitemid 24247854)
29. Giannarelli, R., Aragona, M., Coppelli, A., et al. (2003). Reducing insulin resistance with metformin, the evidence today. Diabetes & Metabolism, 29, S628-S635.
30. Reynolds, T. (1998). Aloe vera, what are the active ingredients? Proceedings of the Active Ingredients Conference, Paris, 1998, 85-93.